Utility of Genetic Screening in Hypertrophic Cardiomyopathy: Prevalence and Significance of Novel and Double (Homozygous and Heterozygous)β-Myosin Mutations
- 1 March 2003
- journal article
- Published by Mary Ann Liebert Inc in Genetic Testing
- Vol. 7 (1) , 21-27
- https://doi.org/10.1089/109065703321560895
Abstract
Genetic screening of the beta-myosin heavy chain gene (MYH7) was evaluated in 100 consecutive unrelated patients with hypertrophic cardiomyopathy (HCM) and 200 normal unrelated subjects. Seventeen beta-myosin mutations were identified in 19 patients. Notably, 13, or 76%, were novel. Mutations were detected in both alleles in two patients: homozygous for Lys207Gln in one, and heterozygous for Pro211 Leu and Arg663His in another. No mutation was detected in the controls. MYH7-associated HCM was associated with more marked left atrial enlargement and syncope than non-MYH7-related HCM. Our findings indicate that: (1) screening methods should allow identification of novel mutations; and (2) more than one sarcomeric mutation may be present in a patient more commonly than is appreciated. Further studies are necessary to ascertain the clinical consequences of the novel and compound gene abnormalities, and to determine whether correlating functional domain to phenotype provides more useful information about the clinical significance of the molecular defects.Keywords
This publication has 20 references indexed in Scilit:
- Hypertrophic CardiomyopathyCirculation, 2001
- Hypertrophic Cardiomyopathy Caused by a Novel α-Tropomyosin Mutation (V95A) Is Associated With Mild Cardiac Phenotype, Abnormal Calcium Binding to Troponin, Abnormal Myosin Cycling, and Poor PrognosisCirculation, 2001
- Malignant Hypertrophic Cardiomyopathy Caused by the Arg723Gly Mutation in β -Myosin Heavy Chain GeneJournal of Molecular and Cellular Cardiology, 2000
- Homozygotes for a R869G Mutation in the β -myosin Heavy Chain Gene have a Severe Form of Familial Hypertrophic CardiomyopathyJournal of Molecular and Cellular Cardiology, 2000
- A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated β-myosin heavy chain genesHuman Genetics, 1998
- Hypertrophic CardiomyopathyCirculation, 1995
- Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1995
- Identification of patients with hypertrophic cardiomyopathy at high risk for sudden deathCurrent Opinion in Cardiology, 1995
- Possible Gene Effect of a Mutant Cardiac β-Myosin Heavy Chain Gene on the Clinical Expression of Familial Hypertrophic CardiomyopathyBiochemical and Biophysical Research Communications, 1994
- A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutationPublished by Elsevier ,1990